For: | Wang CY, Lu W, Hu DS, Wang GD, Cheng XJ. Diagnostic value of controlled attenuation parameter for liver steatosis in patients with chronic hepatitis B. World J Gastroenterol 2014; 20(30): 10585-10590 [PMID: 25132779 DOI: 10.3748/wjg.v20.i30.10585] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v20/i30/10585.htm |
Number | Citing Articles |
1 |
Cristina Margini, Giuseppe Murgia, Guido Stirnimann, Andrea De Gottardi, Nasser Semmo, Stefania Casu, Jaime Bosch, Jean‐François Dufour, Annalisa Berzigotti. Prognostic Significance of Controlled Attenuation Parameter in Patients With Compensated Advanced Chronic Liver Disease. Hepatology Communications 2018; 2(8): 933 doi: 10.1002/hep4.1201
|
2 |
Charlotte Wernberg, Mie Balle Hugger, Maja Thiele. Liver Elastography. 2020; : 441 doi: 10.1007/978-3-030-40542-7_38
|
3 |
Yaohui Wang, Yuhua Zeng, Changwei Lin, Zhiheng Chen. Hypertension and non‐alcoholic fatty liver disease proven by transient elastography. Hepatology Research 2016; 46(13): 1304 doi: 10.1111/hepr.12688
|
4 |
Kee-Huat Chuah, Wah-Kheong Chan. Quantification of Liver Fat in NAFLD: Available Modalities and Clinical Significance. Current Hepatology Reports 2019; 18(4): 492 doi: 10.1007/s11901-019-00493-x
|
5 |
Arinc Ozturk, Joseph R. Grajo, Michael S. Gee, Alex Benjamin, Rebecca E. Zubajlo, Kai E. Thomenius, Brian W. Anthony, Anthony E. Samir, Manish Dhyani. Quantitative Hepatic Fat Quantification in Non-alcoholic Fatty Liver Disease Using Ultrasound-Based Techniques: A Review of Literature and Their Diagnostic Performance. Ultrasound in Medicine & Biology 2018; 44(12): 2461 doi: 10.1016/j.ultrasmedbio.2018.07.019
|
6 |
Wah‐Kheong Chan, Nik Raihan Nik Mustapha, Grace Lai‐Hung Wong, Vincent Wai‐Sun Wong, Sanjiv Mahadeva. Controlled attenuation parameter using the FibroScan® XL probe for quantification of hepatic steatosis for non‐alcoholic fatty liver disease in an Asian population. United European Gastroenterology Journal 2017; 5(1): 76 doi: 10.1177/2050640616646528
|
7 |
Monica Lupsor-Platon, Radu Badea. Noninvasive assessment of alcoholic liver disease using unidimensional transient elastography (Fibroscan<sup>®</sup>). World Journal of Gastroenterology 2015; 21(42): 11914-11923 doi: 10.3748/wjg.v21.i42.11914
|
8 |
|
9 |
Christiane Stern, Laurent Castera. Non-invasive diagnosis of hepatic steatosis. Hepatology International 2017; 11(1): 70 doi: 10.1007/s12072-016-9772-z
|
10 |
Idrees Suliman, Noha Abdelgelil, Farah Kassamali, Tarek I. Hassanein. The Effects of Hepatic Steatosis on the Natural History of HBV Infection. Clinics in Liver Disease 2019; 23(3): 433 doi: 10.1016/j.cld.2019.05.001
|
11 |
Ebada Said, Muhammad Abdel-Gawad, Eman Abdelsameea, Eman Elsayed Elshemy, Nermeen Abdeen, Mohamed Elbasiony, Dalia Omran, Yasser Elesnawy, Alshaimaa Eid, Sameh A. Lashen, Osama Elbahr, Gina Gamal Naguib, Shimaa Afify, Eshak I. Bahbah, Mohamed Alboraie. Vibration Controlled Transient Elastography in Screening for Silent Liver Diseases. European Journal of Gastroenterology & Hepatology 2023; 35(10): 1204 doi: 10.1097/MEG.0000000000002620
|
12 |
Y.H. Yen, F.Y. Kuo, C.C. Lin, C.L. Chen, K.C. Chang, M.C. Tsai, T.H. Hu. Predicting Hepatic Steatosis in Living Liver Donors Via Controlled Attenuation Parameter. Transplantation Proceedings 2018; 50(10): 3533 doi: 10.1016/j.transproceed.2018.06.039
|
13 |
Ana C. Cardoso, Michel Beaugrand, Victor de Ledinghen, Catherine Douvin, Raoul Poupon, Jean-Claude Trinchet, Marianne Ziol, Pierre Bedossa, Patrick Marcellin. Diagnostic performance of controlled attenuation parameter for predicting steatosis grade in chronic hepatitis B. Annals of Hepatology 2015; 14(6): 826 doi: 10.5604/16652681.1171762
|